Hint mode is switched on Switch off

Taysha Gene Therapies, ordinary share
TSHA, US8776191061

Add a stock to WL
Choose all Reset all
Taysha Gene Therapies, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Taysha Gene Therapies Inc is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Taysha Gene Therapies, Inc is primarely in the business of biological products (no diagnostic substances).
  • Issuer
  • Full borrower / issuer name
    Taysha Gene Therapies Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    TSHA
  • Placement
    24.09.2020
  • Lock up period
    180
  • Number of papers
    7,869,566
  • Volume of raised funds
    157.39 mln USD
  • Placement share
    21.97%
  • Final placement price
    20 USD
  • Price change since placement date
    -100%
  • By capitalization
    716.24 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    TSHA
  • Placement
    27.10.2022
  • Lock up period
    180
  • Number of papers
    55,020,086
  • Volume of raised funds
    28 mln USD
  • Placement share
    25.45%
  • Final placement price
    2 USD
  • Price change since placement date
    191.25%
  • By capitalization
    110.04 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    TSHA
  • Placement
    29.05.2025
  • Lock up period
    180
  • Number of papers
    46,868,687
  • Volume of raised funds
    128.89 mln USD
  • Placement share
    18.6%
  • Final placement price
    2.75 USD
  • Price change since placement date
    111.82%
  • By capitalization
    692.79 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

01/06/2026 Taysha Gene Therapies: Submission Of Matters To A Vote Of Security Holders
04/11/2025 Taysha Gene Therapies: Entry Into A Material Definitive Agreement, Results Of Operations And Financial Condition, Financial Statements And Exhibits
02/10/2025 Taysha Gene Therapies: Other Events, Financial Statements And Exhibits
02/06/2025 Taysha Gene Therapies: Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
28/05/2025 Taysha Gene Therapies: Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.